Ficlatuzumab

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Ficlatuzumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target HGF
Identifiers
CAS Number 1174900-84-5 N
ATC code none
KEGG D10123 N
Chemical data
Formula C6446H9954N1718O2026S46
Molecular mass 145.41 kg/mol
 NYesY (what is this?)  (verify)

Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]

Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.[2]

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.


<templatestyles src="Asbox/styles.css"></templatestyles>

<templatestyles src="Asbox/styles.css"></templatestyles>